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Background-—The structure of the aorta is considered to inﬂuence exercise systolic blood pressure (SBP) response, which, in turn,
might impact upon adverse outcomes. The current study sought to investigate the relationship of aortic calciﬁcation and exercise
SBP with adverse outcomes among elderly individuals.
Methods and Results-—We retrospectively reviewed 702 elderly individuals (>65 years of age) without obstructive coronary artery
disease (CAD; luminal stenosis <50%) who underwent coronary computed tomography (CT) and exercise treadmill testing.
DSBPstage2 and DSBPpeak were deﬁned as the difference in systolic blood pressure (SBP) between rest and stage 2 or peak
exercise, respectively. Thoracic aortic calcium score (TACS) and coronary artery calcium score (CACS) were measured using CT
scanning procedures. The primary endpoints were deﬁned as all-cause death, admission for heart failure, obstructive CAD requiring
coronary intervention, and stroke. In multivariable models, DSBPstage2 and DSBPpeak were positively related with log(TACS+1), even
after adjusting for various clinical variables, baseline SBP, and CACS (P<0.001). During a median follow-up period of 65 months,
there were 59 events (8.4%). In a multivariate Cox regression model, independent predictors for all events were age (hazard ratio
[HR], 1.12; 95% CI, 1.05–1.19; P<0.001), dyslipidemia (HR, 1.96; 95% CI, 1.14–3.37; P=0.015), and the 4th quartile of TACS (HR,
1.24; 95% CI, 1.03–1.49; P=0.024). Among individual events, the 4th quartile of TACS was the only independent predictor for
stroke (HR, 2.15; 95% CI, 1.09–5.13; P=0.044), whereas CACS ≥400 mm3 was an independent predictor for obstructive CAD
requiring intervention (HR, 7.04; 95% CI, 1.58–31.36; P=0.010).
Conclusions-—Aortic calciﬁcation was related to SBP response during exercise and was an independent predictor for outcomes,
especially stroke, regardless of resting SBP or CACS. ( J Am Heart Assoc. 2016;5:e003131 doi: 10.1161/JAHA.115.003131)
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D ynamic exercise typically elicits a substantial rise insystolic blood pressure (SBP) without much alteration in
diastolic blood pressure (DBP).1 An early elevation in SBP
during exercise provides further prognostic information
toward cardiovascular outcomes and is known to be an
important marker of various cardiovascular diseases,
including incident hypertension, myocardial infarction, and
stroke, as well as cardiovascular mortality in persons without
overt coronary artery disease (CAD).2–5
Some plausible mechanisms are perhaps responsible, in
part, for the observed exaggerated rise in SBP during exercise.
Past studies documented that an exaggerated rise in SBP is
associated with failure to reduce total peripheral resistance
and impaired endothelial vasodilator function.6 An exaggerated
exercise SBP response is also associated with other estab-
lished cardiovascular risk factors, such as insulin resistance,
hypercholesterolemia, and carotid atherosclerosis.7–9 Arterial
stiffening has also been proposed as a potential mechanism for
an elevated exercise SBP response observed during both
peak10 and submaximal exercise intensities.11
The aorta is an active participant of the cardiovascular
system, and arterial stiffness has been suggested to be a
predictor of cardiovascular morbidity and mortality.12 Aortic
calciﬁcation has previously been independently associated
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with arterial stiffening, isolated systolic hypertension, left
ventricular (LV) hypertrophy, and diastolic dysfunction in
various study populations.13–18 However, the relationship
between exercise SBP and aortic calciﬁcation, and how it
might adversely impact upon health, has not been fully
elucidated, even though a signiﬁcant interaction might exist
between aorta and SBP response during exercise. Computed
tomography (CT) is a useful tool for quantifying aortic
calciﬁcation by aorta calcium scanning,14 and it is possible
that calciﬁcation of the thoracic aorta assessed by CT
scanning may be associated with a higher SBP during exercise
and, subsequently, with poor clinical outcomes. In this study,
we set out to evaluate the role of aortic calciﬁcation on
exercise SBP response and how it might impact on mortality
and various cardiovascular events among elderly individuals
without signiﬁcant CAD who underwent coronary CT and
exercise treadmill testing. Speciﬁcally, we hypothesized that
aortic calciﬁcation would be associated with greater exercise
SBP changes and poor clinical outcomes in the elderly.
Methods
Study Population
We retrospectively reviewed 990 elderly individuals
(≥65 years of age) who underwent both coronary CT and
exercise treadmill testing for evaluation of suspected CAD
within 90 days between tests during 2003 through 2009 at
Severance Cardiovascular Hospital. We excluded 229 individ-
uals with obstructive CAD on coronary CT (luminal stenosis
≥50%), 31 individuals whose CT scan did not include whole
thoracic aorta from aortic arch to diaphragm level, 25
individuals who did not complete 2 stages of the Bruce
protocol at treadmill test, and 3 individuals with atrial
ﬁbrillation. Patients with obstructive CAD were excluded to
abolish the effect of coronary ischemia on exercise blood
pressure and capacity. Hence, 702 elderly individuals without
obstructive CAD comprised the study population. The median
number of days between coronary CT and exercise test was 7
(interquartile range [IQR], 2–14). At the time of index visit,
clinical data were collected from routine medical history,
physical examination, and laboratory tests. Body mass index
(BMI) was calculated from height and weight. Diabetes
mellitus was deﬁned as receiving antidiabetic treatments or a
fasting plasma glucose of ≥126 mg/dL. Current cigarette
smoking was deﬁned as any cigarette smoking in the past
month. Hypertension was deﬁned as SBP ≥140 mm Hg and/or
DBP ≥90 mm Hg or use of antihypertensive agents. Dyslipi-
demia was deﬁned as use of cholesterol-lowering medications
or having serum total cholesterol of ≥200 mg/dL. Primary
endpoints were deﬁned as all-cause death, inpatient admis-
sions for heart failure, obstructive CAD requiring coronary
artery intervention or bypass surgery, stroke, and a composite
of all endpoints. Occurrence of a clinical event was ascer-
tained by review of hospital records and by telephone
interview, if necessary. This study was approved by the
institutional review board of Yonsei University, Severance
Hospital (Seoul, Korea), and all individuals provided informed
consent.
CT Protocol and Image Analysis
Patients were scanned using a 64-section CT scanner
(Sensation 64; Siemens Healthcare, Forchheim, Germany).
For calcium scanning, unenhanced CT was performed with
prospective electrocardiography (EGC)-triggered acquisitions
in mid-diastole using 120 to 140 kV with 150 to 220 mAs,
depending on the patient’s size; 240-ms exposure time per
rotation; 330-ms gantry rotation time; and 6490.6 mm slice
collimation. Calcium scans were reconstructed at 70% of the
R-R interval using a slice thickness of 3 mm with an
increment of 3 mm. Coronary artery and thoracic aorta
calcium scoring was performed on reconstructed images. Foci
of coronary artery, aortic valve, and thoracic aorta were
identiﬁed and scored by an experienced technician who was
masked to the patient’s medical records, using semiautomatic
software (Vitrea 2.0; Vital Images, Minnetonka, MN) and
veriﬁed by imaging cardiologists.19 Lesion-speciﬁc calcium
scores were summed across all lesions identiﬁed within left
main, left anterior descending, left circumﬂex, and right
coronary arteries to provide coronary artery calcium score
(CACS). The thoracic aorta calcium score (TACS) included
calcium scored in the ascending aorta, aortic arch, and
descending aorta to the diaphragm level. An objective volume
scoring method included in the system software was deter-
mined, which provided a score in cubic millimeters.20
Subsequently, standard CT angiography was performed.
Patients without a contraindication to beta-adrenergic block-
ing agents and with initial heart rates higher than 65 beats/
min received a single oral dose of 40 mg of propranolol
hydrochloride 1 hour before coronary CT angiography. Two
types of CT system conﬁgurations were employed: (1) a 64-
slice CT scanner (Sensation 64; Siemens Medical Solutions,
Forchheim, Germany) using retrospective ECG gating with
tube current modulation from 2003 through 2009 with the
following parameters: (1) rotation time: 330 ms, tube voltage:
100 to 120 keV, tube current: 400 to 800 mA, and pitch
factor: 0.2; and (2) a 64-row CT scanner (LightSpeed VCT XT;
GE Healthcare, Milwaukee, WS) using a prospectively ECG-
gated axial technique from 2008 through 2009 with the
following parameters: rotation time: 350 ms, tube voltage:
100 to 120 keV, and tube current: 300 to 900 mA. A real-
time bolus-tracking technique was applied to trigger the
initiation of the scan.
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A symptom-limited exercise treadmill test was performed
according to the Bruce protocol.21 Resting SBP and DBP were
measured in the brachial artery in the seated position. During
the exercise stress test, heart rhythm, SBP, and DBP were
recorded at the end of each stage of exercise, at peak stress,
and during recovery (5 minutes after completion of the
exercise). DSBP was deﬁned as the difference between SBP at
rest and exercise (DSBPstage2, stage 2 exercise; DSBPpeak,
peak exercise). Pulse pressure (PP) was deﬁned as the
difference between SBP and DBP. DPP was deﬁned as the
difference in PP between rest and exercise (DPPstage2, stage 2
exercise; DPPpeak, peak exercise). A 12-lead ECG was
obtained every minute, and a 3-lead ECG for heart rhythm
was monitored continuously. Indications for terminating the
exercise test are previously described.22
Statistical Analysis
Distributions of all relevant variables are reported as percent-
ages or as meansSD for normally distributed variables and
median (with 25–75%) for non-normally distributed variables. To
minimize skewness, we transformed CACS and TACS before
analysis by adding 1 and obtaining the natural logarithm of the
value (ie, log[CACS+1] and log[TACS+1]). We evaluated the linear
relationships by use of univariate linear regression analysis to
determine the independent correlates of exercise DSBPstage2,
DSBPpeak, DPPstage2, and DPPpeak. We performed a univariate
analysis before themultivariate analysis in an effort to ascertain
candidate variables, which might be associated with exercise
changes of SBP and PP. After that, variables that had a P<0.2 in
univariate analysis were retained for subsequent multivariate
linear regression,23 with sex, age, and resting heart rate forced
entry into all models. Multivariate Cox proportional-hazards
regression analysis was employed to determine independent
variables for event-free survival after acquisition of coronary CT.
Kaplan–Meier survival curves were employed to plot all clinical




Demographic characteristics and CT variables of all patients
enrolled in this study are shown in Table 1. Mean age was
694 years, and there were 298 males (42%). Diabetes,
smoking, dyslipidemia, and hypertension were observed in
125 (18%), 95 (14%), 348 (50%), and 392 patients (56%),
respectively. Among those enrolled, 269 (38%), 249 (35%),
and 177 (25%) patients were receiving beta-blockers (BBs),
calcium-channel blockers (CCBs), and angiotensin-converting
enzyme inhibitors (ACEis) or angiotensin receptor blockers
(ARBs). Mean seated SBP and DBP at rest were 12516 and
779 mm Hg, respectively. Median CACS and TACS were 4
(IQR, 0–56) and 442 mm3 (IQR, 125–1235), respectively.
SBP Changes During Exercise Test
Because there are no accepted thresholds or cut-off points for
TACS risk categories, we arbitrarily stratiﬁed TACS into
quartiles to compare BP changes during exercise. Cutoffs for
TACS quartiles were 0 to 125 (ﬁrst quartile), 125 to 442
(second quartile), 442 to 1235 (third quartile), and >1235
(fourth quartile). Trend of changes in DSBP and DPP during
exercise test and at peak exercise according to quartiles of
TACS values are displayed in Table 2. DSBP and DPP were not
signiﬁcantly different among the quartiles of TACS at stage 1
exercise. However, DSBP and DPP were signiﬁcantly higher
during stage 2 and peak exercises and during the recovery




Men, n (%) 298 (42)
Diabetes, n (%) 125 (18)
Smoking, n (%) 95 (14)
Dyslipidemia, n (%) 348 (50)
Hypertension, n (%) 392 (56)
Medications n (%)
Beta-blocker 269 (38)
Calcium-channel blocker 249 (35)
ACEi/ARB 177 (25)
BMI, kg/m2 24.52.7
Total cholesterol/HDL ratio 3.70.9
Resting systolic BP, mm Hg 125.015.7
Resting diastolic BP, mm Hg 76.59.2
Resting PP, mm Hg 48.214.6
Resting heart rate, bpm 57.97.4
CT variables
CACS, mm3 4 (0–56)
log(CACS+1) 2.12.2
TACS, mm3 442 (125–1235)
log(TACS+1) 5.91.9
ACEi indicates angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor
antagonist; BMI, body mass index; BP, blood pressure; CACS, coronary artery calcium
score; CT, computed tomography; HDL, high-density lipoprotein; PP, pulse pressure;
TACS, thoracic aorta calcium score.
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phase for the fourth quartile as compared with the lowest
quartile (all P<0.05).
Relationship Between Aortic Calciﬁcation and
Blood Pressure Response During Exercise Testing
Mean SBP, DBP, and PP during the second stage of exercise
were 15227, 7213, and 8025 mm Hg, respectively.
DSBPstage2 and DPPstage2 were 31.823.1 and 27.323.9
mm Hg, respectively. DSBPpeak and DPPpeak were 53.422.3
and 52.422.6 mm Hg, respectively. The relationship of
standard risk factors and aortic calciﬁcation to resting and
DSBPstage2 orDSBPpeak are summarized in Table 3.Multivariate
regression analysis revealed that log(TACS+1) was indepen-
dently related to resting SBP, even after adjusting for sex, age,
resting heart rate, diabetes, and hypertension (P=0.048).
log(TACS+1) was also related to DSBPstage2 or DSBPpeak, after
adjusting for sex, age, resting SBP, resting DBP, resting heart
rate, other comorbidities, and log(CACS+1) (P=0.001 and 0.010,
respectively). No signiﬁcant associations were observed
between log(TACS+1) and DDBP both at rest and at stage 2 of
exercise. The relationship between standard risk factors and
aortic calciﬁcation to resting andDPPstage2 orDPPpeak is shown
in Table 4. Similar to SBP, log(TACS+1) was independently
associated to resting PP, after adjusting for sex, age, resting
heart rate, diabetics, and log(CACS+1) (P=0.049). log(TACS+1)
also demonstrated a relationship with DPPstage2 and DPPpeak,
even after adjusting sex, age, resting heart rate, other
comorbidities, and log(CACS+1) (all P=0.004).
Predictors for Primary Endpoint
During a median follow-up period of 65 months (IQR, 19–90),
there were 59 events (8.4%), including 11 all-cause deaths
(1.6%), 13 inpatient admissions for heart failures (1.9%), 11
CADs requiring coronary intervention (1.6%), and 24 strokes
(3.4%). TACS was higher in patients with events as compared
with those without an event (26281952 vs 1742995
mm3; P=0.008). However, no signiﬁcant differences in
DSBPstage2 (26.623.8 vs 23.629.6 mm Hg; P=0.455) or
DSBPpeak (53.521.9 vs 48.926.8 mm Hg; P=0.208) were
observed in patients with versus without events. Table 5
reports the multivariate analysis of variables as potential
predictors of all endpoints in the studied population. In
univariate analysis, age and 4th quartile of TACS were
associated with all events (P<0.001 and =0.001, respec-
tively). CACS over 400 mm3 demonstrated a borderline
statistical signiﬁcance (P=0.059). In multivariate analysis,
age (hazard ratio [HR], 1.12; 95% CI, 1.05–1.19; P<0.001),
dyslipidemia (HR, 1.96; 95% CI, 1.14–3.37; P=0.05), and the
4th quartile of TACS (HR, 1.24; 95% CI, 1.03–1.49; P=0.024)
were independent predictors for all-cause events, even after
adjusting for sex and CACS. Among individual events, the 4th
quartile of TACS was the only independent predictor for
stroke (HR, 2.15; 95% CI, 1.09–5.13; P=0.044), whereas
CACS ≥400 mm3 was independently associated with obstruc-
tive CAD requiring intervention (HR, 7.04; 95% CI, 1.58–
31.36; P=0.010). Although the 4th quartile of TACS was a
predictor for heart failure admission in univariate analysis, in
multivariate analysis adjusting for age, sex, dyslipidemia,
resting heart rate, and CACS, it demonstrated a nonsigniﬁcant
relationship with heart failure admission (P=0.119).
Figure 1 demonstrates Kaplan–Meier curves showing dif-
ferences in all event-free survival rates according to quartiles
of TACS. Event-free survival rate was signiﬁcantly lower for
individuals within the 4th quartile of TACS when compared
with the lower quartiles (log-rank, P=0.002). Figure 2 displays
Kaplan–Meier curves for incident stroke and obstructive CAD
Table 2. Change in Systolic Blood Pressure and Pulse Pressure According to Quartiles of TACS
Variable
TACS Quartiles P Value
1st 2nd 3rd 4th P for Trend 1st vs 2nd 1st vs 3rd 1st vs 4th
DSBP
Stage 1 12.921.4 11.220.4 14.024.7 12.421.5 0.864 0.864 0.644 0.824
Stage 2 24.322.4 24.323.8 26.225.9 30.825.0 0.101 0.987 0.471 0.011
Peak exercise 51.221.6 52.124.1 52.222.0 56.821.7 0.027 0.713 0.677 0.017
Recovery 20.520.8 23.520.4 21.720.2 26.020.8 0.039 0.183 0.595 0.016
DPP
Stage 1 18.421.3 17.319.6 18.323.9 18.722.3 0.809 0.603 0.948 0.908
Stage 2 30.721.6 29.320.4 30.223.8 37.425.8 0.013 0.546 0.859 0.012
Peak exercise 50.620.9 51.122.7 50.123.0 58.022.9 0.006 0.838 0.813 0.002
Recovery 22.019.2 24.419.7 22.519.2 28.720.2 0.008 0.244 0.813 0.002
DPP indicates change in pulse pressure during exercise; DSBP, change in systolic blood pressure during exercise; TACS, thoracic aorta calcium score.
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requiring intervention according to quartiles of TACS or CACS.
Incidence of stroke was higher in patients belonging to the
4th quartile of TACS as compared with the lower quartiles
(log-rank, P=0.009), whereas incidence of obstructive CAD
requiring intervention was higher in patients with CACS
≥400 mm3 as compared with those whose CACS was
<400 mm3 (log-rank, P=0.004).
Discussion
In the current study, the high presence of aortic calciﬁcation
was positively correlated with an SBP raise and PP widening
during exercise. Foremost, these relationships remained
signiﬁcant after controlling for potential confounders, includ-
ing CACS and resting blood pressure. In addition, aortic
calciﬁcation was also related with adverse cardiovascular
events, especially stroke, whereas CACS only predicted
obstructive CAD events. Quantitative assessment of aortic
calciﬁcation by use of TACS was feasible, associated with
exercise SBP, and proved a useful surrogate for long-term
clinical outcomes other than obstructive CAD, in elderly
individuals without obstructive CAD determined by coronary
CT angiography, regardless of CACS.
Aortic Calciﬁcation in Populations Without
Obstructive CAD
Aortic calciﬁcation has been reported to be associated with
isolated systolic hypertension in healthy individuals13 and
suggested to be a potential reason for developing arterial
stiffening.24 Aortic calciﬁcation and progressive stiffening of
the large arteries with advancing age results in a widening of
PP and leads to development of isolated systolic hypertension
in the elderly.25,26 Arterial stiffening is one of the suggested
mechanisms for a rise in exercise SBP. We previously
demonstrated that heavy aortic calciﬁcation was associated
with arterial stiffening and also resulted in LV hypertrophy and
diastolic dysfunction in elderly male patients with hyperten-
sion, most likely owing to increased LV afterload associated
with heavily calciﬁed aortic wall and decreased aortic
compliance.24 In the present study, we also veriﬁed that
aortic calciﬁcation, which might be a surrogate for arterial
stiffness, could predict exercise SBP response and cardiovas-
cular outcomes in the elderly who are prone to aortic
calciﬁcation, irrespective of coronary atherosclerosis.
The pathology of aortic calciﬁcation differs to that of
coronary artery calciﬁcation, which is associated with CAD.
Table 3. Relationship of Standard Risk Factors and Aortic Calciﬁcation to Resting and Change in Systolic Blood Pressure During
Exercise
Variable
Resting SBP DSBPstage2 DSBPpeak
Univariate Multivariate Univariate Multivariate Univariate Multivariate
b P Value b P Value b P Value b P Value b P Value b P Value
Male sex 0.042 0.270 0.044 0.321 0.139 <0.001 0.092 0.043 0.150 <0.001 0.149 0.001
Age 0.097 0.011 0.041 0.403 0.032 0.423 0.124 0.009 0.077 0.042 0.085 0.070
Resting SBP — — — — 0.071 0.070 0.044 0.401 0.151 <0.001 0.165 0.001
Resting DBP — — — — 0.114 0.004 0.096 0.056 0.104 0.006 0.041 0.417
Resting heart rate 0.203 <0.001 0.193 <0.001 0.024 0.606 0.010 0.821 0.029 0.514 0.027 0.548
Diabetes 0.079 0.038 0.011 0.869 0.037 0.352 — — 0.085 0.025 0.113 0.013
Hypertension 0.091 0.017 0.058 0.207 0.079 0.047 0.115 0.012 0.031 0.415 — —
Dyslipidemia 0.008 0.839 0.002 — 0.024 0.550 — — 0.084 0.027 0.048 0.283
Use of BB 0.007 0.865 — — 0.091 0.020 0.113 0.012 0.002 0.950 — —
Use of CCB 0.012 0.747 — — 0.053 0.272 — — 0.018 0.641 — —
Use of ACEi/ARB 0.084 0.033 0.033 0.479 0.035 0.377 — — 0.005 0.905 — —
BMI 0.013 0.738 — — 0.060 0.128 — — 0.050 0.190 0.049 0.266
Smoking 0.034 0.365 — — 0.040 0.312 — — 0.045 0.240 — —
Total cholesterol/HDL 0.055 0.188 — — 0.034 0.435 — — 0.035 0.402 — —
log(CACS+1) 0.110 0.004 0.074 0.138 0.002 0.954 0.077 0.126 0.020 0.595 0.084 0.087
log(TACS+1) 0.149 <0.001 0.096 0.048 0.132 0.001 0.175 0.001 0.071 0.060 0.100 0.010
ACEi indicates angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; BB, beta-blocker; BMI, body mass index; CACS, coronary artery calcium score; CCB, calcium-
channel blocker; DBP, diastolic blood pressure; HDL, high-density lipoprotein; SBP, systolic blood pressure; TACS, thoracic aorta calcium score; DSBPpeak, change of systolic blood pressure
during peak exercise; DSBPstage2, change of systolic blood pressure during stage 2 exercise.
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Aortic calciﬁcation reﬂects calciﬁcation in both the intimal
and medial tunica layers of the artery, in contrast to coronary
artery calciﬁcation, which generally occurs in the intimal layer
of an atherosclerotic plaque.27 Medial calciﬁcation is not
associated with atherosclerotic plaque, but is strongly asso-
ciated with aging, diabetes, and end-stage renal disease.28
Interestingly, in the current study, TACS and CACS demon-
strated different prognostic roles in the elderly without
obstructive CAD. TACS predicted adverse cardiac events
other than CAD, whereas CACS mainly predicted signiﬁcant
obstructive CAD. Therefore, aortic calciﬁcation as represented
by TACS might not always reﬂect a sole indicator for
atherosclerosis, which is in contrast to CACS that is often
associated with atherosclerotic plaque on coronary arteries.
Aortic Calciﬁcation, Exercise Blood Pressure, and
Adverse Outcomes
In the present study, heavy aortic calciﬁcation (eg, 4th
quartile of TACS) was related with composite of adverse
outcomes, including all-cause death, stroke, heart failure, and
ischemic heart disease during median follow-up of
65 months, although the studied population constituted
individuals without signiﬁcant CAD at study entrance. Inter-
estingly, stroke was the most frequent adverse event of all
endpoints. It has been reported that descending thoracic
aorta calciﬁcation was associated with incidence of stroke,
and it has been proposed that thoracic aortic calciﬁcation is a
surrogate marker for generalized atherosclerosis whereby
plaques in the aorta itself might be a potential stroke origin.29
In addition, we may add that increased SBP might further
provoke stroke and adverse events in individuals with a heavy
calcium deposit. In a population-based study, Kurl et al.4
reported an increased risk of stroke in subjects with increased
SBP, and suggested that an increase in the risk of endothelial
injury from high exercise SBP, as well as underlying arte-
riosclerotic disease or structural vascular changes, may reﬂect
some of the plausible mechanisms involved. The association
between DSBP and aortic calciﬁcation was similarly demon-
strated during both submaximal and maximal exercise. Yet,
DSBP and DPP during exercise did not predict clinical
outcomes in the current study population. This discrepancy
might be, in part, attributed to the fact that the population
examined in this study was elderly, andmost patients were only
capable of completing the exercise test at a low-intensity
workload. Further still, most of the enrolled population was
prescribed antihypertensive medication, including BB and CCB,
which could have also altered the SBP response to exercise.
Although not statistically signiﬁcant in multivariate analy-
sis, TACS was associated with incidence of heart failure
Table 4. Relationship of Standard Risk Factors and Aortic Calciﬁcation to Resting and Change in Pulse Pressure During Exercise
Variable
Resting PP DPPstage2 DPPpeak
Univariate Multivariate Univariate Multivariate Univariate Multivariate
b P Value b P Value b P Value b P Value b P Value b P Value
Male sex 0.011 0.771 0.021 0.643 0.086 0.030 0.125 0.060 0.098 0.010 0.056 0.217
Age 0.151 <0.001 0.079 0.087 0.027 0.492 0.081 0.094 0.066 0.085 0.065 0.175
Resting PP — — — — 0.033 0.411 — — 0.110 0.004 0.121 0.010
Resting heart rate 0.152 0.001 0.135 0.003 0.028 0.553 0.003 0.952 0.005 0.914 0.007 0.877
Diabetes 0.157 <0.001 0.102 0.023 0.076 0.056 0.080 0.088 0.117 0.002 0.138 0.003
Hypertension 0.061 0.112 — — 0.042 0.300 — — 0.018 0.647 — —
Dyslipidemia 0.021 0.579 — — 0.050 0.209 — — 0.069 0.072 0.021 0.642
Use of BB 0.035 0.363 — — 0.085 0.038 0.121 0.009 0.022 0.570 — —
Use of CCB 0.012 0.753 — — 0.032 0.426 — — 0.019 0.621 — —
Use of ACEi/ARB 0.098 0.011 0.038 0.393 0.044 0.274 — — 0.041 0.290 — —
BMI 0.003 0.942 — — 0.074 0.063 0.125 0.007 0.053 0.164 0.047 0.304
Smoking 0.035 0.351 — — 0.024 0.541 — — 0.033 0.391 — —
Total cholesterol/HDL 0.046 0.265 — — 0.002 0.959 — — 0.045 0.280 — —
log(CACS+1) 0.108 0.005 0.070 0.153 0.034 0.397 0.030 0.566 0.018 0.640 0.101 0.055
log(TACS+1) 0.173 <0.001 0.097 0.049 0.105 0.008 0.128 0.004 0.086 0.023 0.144 0.004
ACEi indicates angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; BB, beta-blocker; BMI, body mass index; CACS, coronary artery calcium score; CCB, calcium-
channel blocker; HDL, high-density lipoprotein; PP, pulse pressure; TACS, thoracic aorta calcium score; DPPpeak, change of pulse pressure during peak exercise; DPPstage2, change of pulse
pressure during stage 2 exercise.
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Table 5. Cox Proportional Hazards Regression for Predictors of Outcomes
Outcome Predictor
Univariate Multivariate
HR (95% CI) P Value HR (95% CI) P Value
All events Age 1.14 (1.08–1.22) <0.001 1.12 (1.05–1.19) <0.001
Male sex 1.20 (0.72–2.01) 0.488 1.06 (0.62–1.81) 0.826
Hypertension 1.15 (0.68–0.95) 0.603 — —
Diabetes 0.82 (0.41–1.61) 0.557 — —
Dyslipidemia 1.60 (0.95–2.70) 0.081 1.96 (1.14–3.37) 0.015
Resting heart rate 1.01 (0.97–1.05) 0.722 —
BMI 0.97 (0.88–1.06) 0.461 —
Smoking 1.19 (0.58–2.42) 0.635 —
CACS ≥400 mm3 2.26 (0.97–5.27) 0.059 1.83 (0.75–4.48) 0.184
TACS 4th vs 1st to 3rd quartiles 2.41 (1.44–4.04) 0.001 1.24 (1.03–1.49) 0.024
All-cause death Age 1.27 (1.12–1.44) <0.001 1.26 (1.09–1.46) 0.002
Male sex 1.08 (0.33–3.53) 0.904 0.77 (0.22–2.78) 0.694
Hypertension 1.02 (0.31–3.33) 0.980 — —
Diabetes 0.38 (0.05–2.99) 0.360 — —
Dyslipidemia 0.96 (0.29–3.16) 0.949 — —
Resting heart rate 0.93 (0.83–0.13) 0.155 0.96 (0.85–1.08) 0.468
BMI 0.69 (0.55–0.86) 0.001 0.66 (0.50–0.87) 0.003
Smoking 0.66 (0.08–5.16) 0.692 — —
CACS ≥400 mm3 0.99 (0.21–4.59) 0.991 0.47 (0.65–1.74) 0.814
TACS 4th vs 1st to 3rd quartiles 1.67 (0.49–5.72) 0.412 0.93 (0.25–3.49) 0.908
Heart failure Age 1.16 (1.02–1.32) 0.029 1.08 (0.88–1.33) 0.483
Male sex 1.71 (0.54–5.40) 0.360 1.89 (0.33–10.69) 0.473
Hypertension 0.61 (0.19–1.91) 0.392 — —
Diabetes 1.34 (0.36–4.94) 0.665 — —
Dyslipidemia 2.32 (0.70–7.72) 0.170 3.63 (0.62–21.28) 0.152
Resting heart rate 1.04 (0.99–1.09) 0.155 1.03 (0.15–7.25) 0.957
BMI 0.98 (0.80–1.20) 0.848 — —
Smoking 2.18 (0.59–8.04) 0.244 — —
CACS ≥400 mm3 1.80 (0.23–13.96) 0.574 1.06 (0.15–7.25) 0.957
TACS 4th vs 1st to 3rd quartiles 3.20 (1.03–9.93) 0.044 4.13 (0.69–24.62) 0.119
Obstructive CAD Age 1.06 (0.91–1.23) 0.450 1.03 (0.88–1.21) 0.707
Male sex 1.56 (0.48–5.13) 0.460 0.04 (0.29–3.77) 0.956
Hypertension 0.69 (0.21–2.26) 0.537 — —
Diabetes 2.31 (0.68–7.89) 0.183 0.58 (0.17–1.94) 0.373
Dyslipidemia 1.29 (0.39–4.22) 0.678 — —
Resting heart rate 0.99 (0.89–1.10) 0.825 — —
BMI 1.02 (0.83–1.26) 0.826 — —
Smoking 1.40 (0.32–6.48) 0.667 — —
CACS ≥400 mm3 7.12 (1.89–26.87) 0.004 7.04 (1.58–31.36) 0.010
TACS 4th vs 1st to 3rd quartiles 1.67 (0.49–5.70) 0.414 1.45 (0.39–5.39) 0.583
Continued
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admission during follow-up in univariate analysis—an obser-
vation that perhaps warrants further study, given that heart
failure has been reported to be associated with arterial
stiffening in the elderly.30 Albeit, because our data did not
include the measurement of arterial stiffening, further larger
studies are clearly required to assess the association, if any,
between aortic calciﬁcation, arterial stiffening, and incidence
of heart failure. However, we might speculate that aortic
calciﬁcation represents not only atherosclerotic burden, but
also resultant vascular structural changes, which can cause
stiffening of the aorta, a rise in exercise SBP, and may
exacerbate poor clinical outcomes, such as heart failure and
stoke. The role of anticalciﬁcation strategies as a novel
therapeutic approach for exaggerated SBP response and
heavy aortic calciﬁcation may warrant further investigation.
CT as a Screening Test Using Aortic Calcium
Scoring
In current practice, the use of noncontrast CT of the chest is
rapidly emerging as a screening tool for identifying asymp-
tomatic patients at high risk of CAD, as well as for lung cancer
screening.31 Coronary CT angiography is gaining further
consideration as a gatekeeper or useful alternative for invasive
coronary angiography.32 Although information regarding tho-
racic aortic calciﬁcation can also be assessed from CT of the
thoracic area, it does not currently have a role in clinical
decision making. Notably, it has been previously reported that
TACS does not further improve prediction of events over and
above CACS.33 Albeit, the current study ﬁndings indicate that
the measurement of TACS, rather than CACS, might reﬂect a
novel surrogate for detection of vulnerable aortas that may
provoke a raised SBP during exercise and possibly lead to poor
clinical outcomes in elderly individuals other than obstructive
CAD. Therefore, calculation of TACS in addition to coronary CT
angiography, and not CACS, might prove more beneﬁcial
for screening populations who are at high risk for future
cardiovascular disease, especially among elderly individuals
without obstructive CAD. Though clearly, further studies are
needed to test this speculation.
Study Limitations
The current study ﬁndings were based on a retrospective
analysis, which may have inferred some biases. Despite this,




HR (95% CI) P Value HR (95% CI) P Value
Stroke Age 1.12 (1.02–1.23) 0.014 1.10 (0.99–1.22) 0.076
Male sex 0.935 (0.42–2.17) 0.871 0.80 (0.34–1.89) 0.613
Hypertension 2.35 (0.93–5.97) 0.072 0.33 (0.76–5.04) 0.139
Diabetes 0.35 (0.08–1.49) 0.155 1.96 (0.76–5.04) 0.163
Dyslipidemia 1.87 (0.82–4.30) 0.139 1.83 (0.77–4.37) 0.171
Resting heart rate 1.02 (0.97–1.07) 0.402 — —
BMI 1.07 (0.94–1.23) 0.312 — —
Smoking 0.92 (0.28–3.10) 0.896 — —
CACS ≥400 mm3 1.733 (0.41–7.38) 0.457 1.89 (0.42–8.56) 0.410
TACS 4th vs 1st to 3rd quartiles 2.89 (1.30–6.42) 0.009 2.15 (1.09–5.13) 0.044
BMI indicates body mass index; CACS, coronary artery calcium score; CAD, coronary artery disease; CI, conﬁdential interval; HDL, high-density lipoprotein; HR, hazard ratio; TACS, thoracic
aorta calcium score.
Figure 1. Kaplan–Meier curves displaying the differences in all
event-free survival rates according to thoracic aorta calcium score
quartiles.
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images, in an effort to avoid any of the possible biases that
may have arisen. It remains uncertain precisely how much of
the calciﬁcation detected in the aorta reﬂects calciﬁed
atherosclerotic plaque or nonatherosclerotic plaque, given
that intimal calciﬁcation cannot be differentiated from medial
calciﬁcation through CT scanning. Also, considering that our
ﬁndings are based upon an observational cohort of elderly
patients (≥65 years) without obstructive CAD, these obser-
vations may not be generalizable to other populations, and
therefore our results should be interpreted with caution.
Considering DSBP was not statistically different between
individuals with and without an event in the current study, it is
not clear whether a rise in exercise SBP mainly mediated poor
clinical outcomes in the background of high TACS. However,
one of the possibilities why TACS displayed better prediction
of outcomes than DSBP would be attributed to the fact that
there was relatively more variance in DSBP than in TACS
measurement. Arterial stiffness was not measured, and
therefore further studies with concurrent measures of arterial
stiffness, aortic calciﬁcation, and exercise blood pressure are
warranted to support our hypothesis. In addition, forthcoming
studies with larger populations are required, given that we
examined multiple endpoints, which can cause numerous
issues attributed to multiple testing, and may heighten the
probability of a type 1 error. Given that ﬁtness is one of the
most important factors for inﬂuencing SBP change during
exercise, it would also be beneﬁcial to perform the latter
analysis while controlling for physical ﬁtness, although
because of the retrospective nature of the current study, it
was beyond the scope of our investigation to obtain additional
data regarding patients’ ﬁtness. Despite this, resting heart
rate is a well-known surrogate of cardiorespiratory ﬁtness and
has been utilized in several previous studies.34,35 Moreover,
TACS demonstrated an independent association with resting
and exercise SBP, even after controlling for resting heart rate.
Hence, we speculate that presence of an association between
TACS and SBP might persist even after adjusting for physical
ﬁtness. Though clearly, additional studies with better-deﬁned
measures of physical ﬁtness are needed to reinforce this
contention.
Conclusion
In this study, presence of aortic calciﬁcation was related to
elevated SBP during exercise and was a robust predictor of
clinical outcomes in elderly individuals without obstructive
CAD. Though additional studies are needed to conﬁrm these
associations, measurement of TACS from coronary CT
scanning may prove useful for predicting exercise SBP
response and subsequent adverse clinical outcomes, espe-
cially stroke, at least in elderly individuals without obstructive
CAD.
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Figure 2. Kaplan–Meier curves displaying the differences in (A) stroke rates and (B) obstructive
coronary artery disease according to quartiles of thoracic aorta calcium score (TACS) or coronary artery
calcium score (CACS).
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